Compare HERE & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HERE | COYA |
|---|---|---|
| Founded | 2019 | 2020 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.1M | 110.0M |
| IPO Year | 2022 | 2022 |
| Metric | HERE | COYA |
|---|---|---|
| Price | $1.85 | $4.90 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $15.80 |
| AVG Volume (30 Days) | 22.1K | ★ 136.0K |
| Earning Date | 06-05-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $7,945,753.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $79.29 | $763.10 |
| P/E Ratio | $2.83 | ★ N/A |
| Revenue Growth | N/A | ★ 123.57 |
| 52 Week Low | $1.50 | $3.71 |
| 52 Week High | $5.80 | $7.75 |
| Indicator | HERE | COYA |
|---|---|---|
| Relative Strength Index (RSI) | 40.82 | 56.68 |
| Support Level | $1.67 | $4.45 |
| Resistance Level | $1.95 | $5.18 |
| Average True Range (ATR) | 0.07 | 0.22 |
| MACD | 0.00 | 0.07 |
| Stochastic Oscillator | 20.00 | 99.00 |
Here Group Ltd is dedicated to creating collectible pop toys that evoke joy and emotional resonance. The group design and compelling storytelling, which provide users with a collecting experience that blends artistic value with emotional warmth, continuously convey a joyful and immersive brand culture. Adhering to the brand philosophy of joy, integrity, wonder, and co-creation, the company is building a vibrant ecosystem connecting creativity and emotion, working hand-in-hand with overall toy enthusiasts to create, share, and transmit dreams.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.